Cargando…
iGEM and Gene Drives: A Case Study for Governance
Gene drives have already challenged governance systems. In this case study, we explore the International Genetically Engineered Machine (iGEM) competition's experiences in gene drive-related research and lessons in developing, revising, and implementing a governance system. iGEM's experien...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892970/ https://www.ncbi.nlm.nih.gov/pubmed/35020492 http://dx.doi.org/10.1089/hs.2021.0157 |
_version_ | 1784662286171897856 |
---|---|
author | Millett, Piers Alexanian, Tessa Palmer, Megan J. Evans, Sam Weiss Kuiken, Todd Oye, Kenneth |
author_facet | Millett, Piers Alexanian, Tessa Palmer, Megan J. Evans, Sam Weiss Kuiken, Todd Oye, Kenneth |
author_sort | Millett, Piers |
collection | PubMed |
description | Gene drives have already challenged governance systems. In this case study, we explore the International Genetically Engineered Machine (iGEM) competition's experiences in gene drive-related research and lessons in developing, revising, and implementing a governance system. iGEM's experiences and lessons are distilled into 6 key insights for future gene drive policy development in the United States: (1) gene drives deserve special attention because of their potential for widescale impact and remaining uncertainty about how to evaluate intergenerational and transboundary risks; (2) an adaptive risk management approach is logical for gene drives because of the rapidly changing technical environment; (3) review by individual technical experts is limited and may fail to incorporate other forms of expertise and, therefore, must be complemented with a range of alternative governance methods; (4) current laboratory biosafety and biosecurity review processes may not capture gene drive research or its components in practice even if they are covered theoretically; (5) risk management for research and development must incorporate discussions of values and broader implications of the work; and (6) a regular technology horizon scanning capacity is needed for the early identification of advances that could pose governance system challenges. |
format | Online Article Text |
id | pubmed-8892970 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Mary Ann Liebert, Inc., publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-88929702022-03-03 iGEM and Gene Drives: A Case Study for Governance Millett, Piers Alexanian, Tessa Palmer, Megan J. Evans, Sam Weiss Kuiken, Todd Oye, Kenneth Health Secur Case Studies Gene drives have already challenged governance systems. In this case study, we explore the International Genetically Engineered Machine (iGEM) competition's experiences in gene drive-related research and lessons in developing, revising, and implementing a governance system. iGEM's experiences and lessons are distilled into 6 key insights for future gene drive policy development in the United States: (1) gene drives deserve special attention because of their potential for widescale impact and remaining uncertainty about how to evaluate intergenerational and transboundary risks; (2) an adaptive risk management approach is logical for gene drives because of the rapidly changing technical environment; (3) review by individual technical experts is limited and may fail to incorporate other forms of expertise and, therefore, must be complemented with a range of alternative governance methods; (4) current laboratory biosafety and biosecurity review processes may not capture gene drive research or its components in practice even if they are covered theoretically; (5) risk management for research and development must incorporate discussions of values and broader implications of the work; and (6) a regular technology horizon scanning capacity is needed for the early identification of advances that could pose governance system challenges. Mary Ann Liebert, Inc., publishers 2022-02-01 2022-02-15 /pmc/articles/PMC8892970/ /pubmed/35020492 http://dx.doi.org/10.1089/hs.2021.0157 Text en © Piers Millett et al., 2021; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by/4.0/This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Case Studies Millett, Piers Alexanian, Tessa Palmer, Megan J. Evans, Sam Weiss Kuiken, Todd Oye, Kenneth iGEM and Gene Drives: A Case Study for Governance |
title | iGEM and Gene Drives: A Case Study for Governance |
title_full | iGEM and Gene Drives: A Case Study for Governance |
title_fullStr | iGEM and Gene Drives: A Case Study for Governance |
title_full_unstemmed | iGEM and Gene Drives: A Case Study for Governance |
title_short | iGEM and Gene Drives: A Case Study for Governance |
title_sort | igem and gene drives: a case study for governance |
topic | Case Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892970/ https://www.ncbi.nlm.nih.gov/pubmed/35020492 http://dx.doi.org/10.1089/hs.2021.0157 |
work_keys_str_mv | AT millettpiers igemandgenedrivesacasestudyforgovernance AT alexaniantessa igemandgenedrivesacasestudyforgovernance AT palmermeganj igemandgenedrivesacasestudyforgovernance AT evanssamweiss igemandgenedrivesacasestudyforgovernance AT kuikentodd igemandgenedrivesacasestudyforgovernance AT oyekenneth igemandgenedrivesacasestudyforgovernance |